These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8160251)

  • 1. Important metabolites to measure in pharmacodynamic studies of chlorpromazine.
    Chetty M; Moodley SV; Miller R
    Ther Drug Monit; 1994 Feb; 16(1):30-6. PubMed ID: 8160251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M; Gouws E; Miller R; Moodley SV
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):77-82. PubMed ID: 10082231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels.
    Chetty M; Pillay VL; Moodley SV; Miller R
    Eur Neuropsychopharmacol; 1996 May; 6(2):85-91. PubMed ID: 8791032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein binding of chlorpromazine in vivo and in vitro: effect of chlorpromazine metabolite on chlorpromazine protein binding in rat.
    Sato S; Koshiro A
    Biol Pharm Bull; 1995 Apr; 18(4):586-92. PubMed ID: 7655433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
    Wode-Helgodt B; Alfredsson G
    Psychopharmacology (Berl); 1981; 73(1):55-62. PubMed ID: 6785790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay for the N-oxide metabolite of chlorpromazine in human plasma and its application to a pharmacokinetic study in healthy humans.
    Yeung PK; Hubbard JW; Korchinski ED; Midha KK
    J Pharm Sci; 1987 Oct; 76(10):803-8. PubMed ID: 3430345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of storage on the plasma concentration of chlorpromazine and six of its metabolites.
    Chetty M; Miller R
    Ther Drug Monit; 1991 Jul; 13(4):350-5. PubMed ID: 1780969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
    Suzuki H; Gen K; Inoue Y
    J Psychopharmacol; 2013 Apr; 27(4):396-400. PubMed ID: 23427194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic monitoring of chlorpromazine. III: Minimal interconversion between chlorpromazine and metabolites in human blood.
    Hawes EM; Hubbard JW; Martin M; McKay G; Yeung PK; Midha KK
    Ther Drug Monit; 1986; 8(1):37-41. PubMed ID: 3961895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
    Makanjuola RO; Dixon PA; Oforah E
    Trop Geogr Med; 1988 Jan; 40(1):31-3. PubMed ID: 3381314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
    Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma nor1-chlorpromazine concentrations: effects of age, race, and sex.
    Young RC
    Ther Drug Monit; 1986; 8(1):23-6. PubMed ID: 3961892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration and distribution of thioridazine and metabolites in schizophrenic post-mortem brain tissue.
    Svendsen CN; Hrbek CC; Casendino M; Nichols RD; Bird ED
    Psychiatry Res; 1988 Jan; 23(1):1-10. PubMed ID: 3363012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of response to chlorpromazine treatment in schizophrenics.
    Sakurai Y; Nakahara T; Takahashi R
    Psychopharmacologia; 1975 Oct; 44(2):195-203. PubMed ID: 1105634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of chlorpromazine and key metabolites.
    Yeung PK; Hubbard JW; Korchinski ED; Midha KK
    Eur J Clin Pharmacol; 1993; 45(6):563-9. PubMed ID: 8157044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic monitoring of chlorpromazine. IV: Comparison of a new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolites.
    Midha KK; Hubbard JW; Cooper JK; Gurnsey T; Hawes EM; McKay G; Chakraborty BS; Yeung PK
    Ther Drug Monit; 1987 Sep; 9(3):358-65. PubMed ID: 3672582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of radioimmunoassay for chlorpromazine.
    Kawashima K; Dixon R; Spector S
    Eur J Pharmacol; 1975; 32(02):195-202. PubMed ID: 1149806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.
    Alfredsson G; Wode-Helgodt B; Sedvall G
    Psychopharmacology (Berl); 1976 Jul; 48(2):123-31. PubMed ID: 826923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.